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ABSTRACT 
The following thesis proposes the question if current scientific data 
supports the hypothesis that an acute myocardial infarction, not identified by 
gross symptoms, can be visualized by using apoptotic signaling biomarkers as a 
diagnostic tool to complement a post-mortem autopsy. The biochemistry and 
mechanisms of irreversible cellular death is presented and supported through 
published experimental, clinical and case studies. Furthermore, the aforesaid 
biomarkers have been observed in the cardiac myocyte in elevated levels 
associated with hypoxic ischemia.  In addition, the physical characteristic of DNA 
fragmentation is addressed to visualize apoptotic injury due to hypoxic ischemic 
conditions. Although the quality of evidence lacked published data to suggest 
one immunochemical staining method positively identifies a myocardial infarction, 
there is adequate data to suggest that a combination of staining methods can be 
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utilized as a tool to positively identify and diagnose an acute myocardial 
infarction. 
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I. Introduction 
Sudden cardiac death is one of the leading causes of death in the 
United States and is a diagnostic challenge for forensic pathologists [1, 2]. 
In 2006, one out of every three deaths was attributed to cardiovascular 
disease. Sudden cardiac death can occur very rapidly, usually within one 
hour of an ischemic event with or without observed physical signs of 
myocyte damage [3]. It has been estimated that over 4000 individuals in 
the United States die every year from sudden cardiac death [3].   
This investigation proposes the question if current scientific data 
support the hypothesis that an acute myocardial infarction, not identified 
by gross symptoms, can be visualized by using apoptotic signaling 
biomarkers as a diagnostic tool to complement a post-mortem autopsy. To 
date, sudden unexplained death, in apparently healthy individuals, raises 
suspicion that a biochemical event has occurred due to cardiac failure. 
This paper will review the cardiovascular system under normative 
conditions and introduce the topic of apoptotic proteins prevalent during 
an irreversible ischemic heart attack. This investigation will review these 
protein based biomarkers as an immunohistochemical tool to visualize the 
function of apoptosis not evident during gross examination. The quality of 
evidence will be analyzed and various experiments regarding expressed 
biomarkers indicative of irreversible cellular damage will be reviewed. This 
2 
 
information will be discussed in order to further complement research and 
experiments in the future.      
 
 
The cardiovascular system         
The cardiovascular system is a network of blood vessels, 
composed of arteries, veins, capillaries and the heart which pumps blood 
throughout the body [4, 5]. Deoxygenated blood enters the heart through 
one of two veins: the superior and inferior vena cavae. De-oxygenated 
blood converges and meets in the right atrium chamber of the heart. As 
the heart continuously pumps, blood from the right atrium passes through 
the organ’s tricuspid valve and enters the bottom right ventricular 
chamber. Blood travels through another valve, the pulmonary valve, and 
diverges into one of two pulmonary arteries. The pulmonary arteries send 
deoxygenated blood through the capillary system of the lungs where gas 
exchange of carbon dioxide and oxygen takes place between the 
capillaries and the alveoli of the lungs. Oxygenated blood converges into 
the left atrium from the left and right pulmonary veins. The blood is then 
pumped through the mitral valve and into the left ventricle of the heart.  
There, where the myocardium of the left ventricle is thickest, the heart 
distributes the blood throughout the rest of the body [4] (Figure 1).  
 
3 
 
 
 
Figure 1 shows illustration of the human heart. The arrows denote 
unidirectional blood flow initiating from the superior and inferior vena 
cavae [6].  
 
        The circulatory system has a common basic histological structure  [7] 
(outlined in Table 1). Depending on the myocardial section observed, the 
outline is similar in cardiac tissue, arteries and veins. For example, the 
tunica intima is both consistent with the inner lining of the left ventricle 
which also corresponds to the inner lining of an artery. The tunica media 
and the tunica adventitia make up the intermediate and the outside layer 
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of the circulatory structures respectively. Figure 2 shows the various 
layers of the Tunica intima (TI), Tunica media (TM), and the Tunica 
adventia (TA) [7].  
 
 
Figure 2 shows a magnification micrograph depicting complex 
atherosclerosis. It is approximately 1/3 millimeters thick distal to the right 
coronary artery. The Tunica intima is usually approximately 10 
micrometers [8]. 
 
 
 
TA 
TM 
TI 
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Basic Structure Description 
Tunica intima; TI 
(Endocardium) 
Inner Lining; flat 
epiethelial cells 
Tunica media; TM 
(Myocardium) 
Intermediate muscular 
layer 
Tunica 
adventitia;TA 
(epicardium) 
 
Supporting outer layer 
 
Table 1 lists the histological cross-section description of the circulatory 
system [7]. 
 
There are a few differences between cardiac muscle and skeletal 
muscle. The skeletal muscle of the body is attached to bone by tendons 
that allows for structural movement. The heart is attached to arteries and 
veins (as opposed to tendons) and is an organ designed to continuously 
function even when the body is at a resting state. Somatic motor neurons 
from the brain transmit electrical signals to innervate skeletal muscle 
which cannot initiate its own signal for contraction [4].   
The heart’s unique network of intercalated disks helps to increase 
electrical cellular communication between cardiac myocytes.  
Desmosomes, held together by cadherin proteins, allow the energy 
created by contraction to be transferred to each neighboring cell [4]. Gap 
junctions, located in between the cardiac myocytes, help regulate small 
ions and molecules. Cardiac depolarization occurs when electrical 
conduction created spreads through the septum of the heart. The purkinje 
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fibers, located at the bottom of the ventricles, allow cardiac depolarization 
to spread upward from the heart’s apex, nearly simultaneously, 
contracting cardiac ventricular fibers [4]. 
 
 
Physiological imbalances that lead to apoptosis    
 Edston et al. states that “sudden cardiac death is a challenging 
subject to forensic pathologists and the majority of cases is probably due 
to acute coronary artery occlusion by ruptured plaque or thrombus” [2] 
(Figure 4). Cardiovascular disease and other symptoms of atherosclerosis 
may produce an arrhythmia but not before the functional biochemical 
process of apoptosis precedes first. Apoptosis is the cell’s “latent suicide 
program” [9] which results in damage to the DNA. This results in the 
elimination of the cell’s ability to function and grow [9]. For example, 
studies have indicated elevated levels of biomarkers related to apoptosis, 
such as cytochrome C and the B-Cell Lymphoma (Bcl-2) proteins. These 
proteins are correlated with the symptoms of inflammation and hypoxic 
ischemia which coincides with irreversible cardiac damage [10]. This, and 
the addition of physiological stress induced by the lack of oxygen, may 
force the cardiac myocyte to undergo adaptive responses that will test the 
cell’s limitations, forcing to choose life or death [11]. 
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 Atherosclerosis, the narrowing of the lumina of the coronary 
arteries, can limit the amount of blood passing through the heart. Plaque 
ruptures and exposes lipids and collagens, initiating platelet aggregation 
and thrombus formation from within an artery [11]. This leads to a low 
ventricular output and the purkinje fibers of the heart fail to fire the 
necessary amount of electrochemical signals transmitted for the heart to 
function normally. This event leads to a fatal abnormal cardiac rhythm or 
an arrhythmia [4, 7].  
The physiological sudden sign of atherosclerosis results in a 
condition known as ischemia:  a restriction of blood supply due to reduced 
blood flow; typically caused by heart failure, shock, and thrombosis [4] 
(Figure 3). The time in which an individual dies from a heart attack, upon 
observation of the initial onset of symptoms, may range from 
instantaneous death to death within 24 hours [11, 31].  When 
instantaneous death occurs, physical changes in the heart are not always 
apparent. This can result in a misdiagnosis by physicians and forensic 
pathologists based upon symptoms that may or may not have occurred.   
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Figure 3 showing a chart of hypoxic ischemia due to narrowing 
atherosclerosis. A change in the cytosolic and mitochondrial portion of the 
cell is depicted [31]. 
 
 
Investigation within forensic medicine 
When irreversible cellular injury is followed by death of the 
individual, the forensic medico-legal death investigator’s duties include the 
examination for any signs of injury observed and the inspection for rigor 
and livor mortis. The items found on the deceased strictly belong to the 
medico-legal death investigator. Any item possibly found relating to the 
victim’s death should be made accessible to the forensic pathologist [12]. 
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The forensic investigator must observe and document any physical 
signs of sudden death. The finding of the body in an uncomfortable or 
unusual position ,such as contortion or twisting, is usually a sign of sudden 
death [12]. Butyric acid found alongside the body may be mistaken for 
spewed content. The discovery of blood at a scene may also be a sign of 
sudden death and may mislead investigators into thinking a crime has 
occurred [12].  
           The chain of custody for the deceased body is given to a forensic 
pathologist who is a licensed medical physician or an elected forensic 
coroner. The examiner is responsible for the identification of the deceased 
and the interpretation of the significance of any biological and physical 
evidence [12].  
 
 
Autopsy performance 
The main objective of a forensic autopsy is to assess the cause and 
manner of death based upon an all symptoms, medical records and 
testimony given to the forensic pathologist. The forensic pathologist  
records and describes any findings during the physical assessment [13].   
The autopsy begins with an initial assessment of artifacts and 
trauma found on the body.  Afterwards, a “Y”-shaped incision is performed 
on the individual. Blood is drained and organs are removed either en-bloc 
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or individually.            
 An incision is made behind the ear and extended to the forehead 
towards the opposite ear to expose the skull. The skull is removed with a 
saw, or other hand tool, to expose and evaluate the brain. During the 
procedural autopsy, if no cause of death was found after gross 
examination, the pathologist will sample all organs of the deceased for 
microscopic examination and preservation. Chain of custody is maintained  
for all specimens which are created and preserved [12]. The forensic 
pathologist may submit tissue from any organ for drug and laboratory 
testing if the cause of death is not recognized [12]. 
 The technique for observing an adult human heart requires the 
forensic pathologist to obtain sections of cardiac tissue and preserve it for 
further testing [14]. The pathologist may use the body mass index as a 
tool to estimate whether or not an individual’s heart is enlarged by 
comparing the weight and height of the deceased with the weight of the 
heart. The pathologist  would look for external abnormalities outside of the 
heart before surgical dissection [14]. Once the external features of the 
heart have been evaluated, the pathologist will dissect the coronary artery 
of the heart by creating cross-sections, approximately two to three 
millimeters thick, to visualize for possible atherosclerosis and coronary 
stenosis: the abnormal narrowing of blood vessels [15]. Gross 
examination should include the documentation of the heart’s ventricular 
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size, abnormalities to both the tricuspid and mitral valve, such as 
calcification and/or leaflet deviation and the degree of fat observed outside 
the heart’s cardiac tissue [14].  
 
 
Forensic significance       
 When dealing with a postmortem situation, the manner of death is 
not always apparent. Some signs that may suggest sudden cardiac death 
include the victim’s hands clenching their chest or sudden body collapse. 
The more contorted and twisted the body is found may be a sign of 
sudden death [12]. Typically, the medical examiner would see the 
narrowing of blood vessels and adipose tissue located around the heart 
that may indicative of atherosclerotic coronary artery disease. However 
these signs may not help indicate death during a post-mortem autopsy. 
The case is considered a negative autopsy, and therefore; an effective 
diagnosis is needed.  In some scenarios, no thrombus or ischemic heart 
changes can be observed [12].   
The following case illustrates a scenario in which a deceased 44 
year old, white male body was received by medical officials (Figure 4).  
Upon arrival, the body showed signs of rigor mortis, and purple fixed 
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lividity. The victim had on his clothes and his wallet with money and 
personal belongings intact.    
 
Figure 4 depicting the 44 year old deceased white male found by medical 
officials. 
Upon external examination, the body measured at approximately 
72 inches and weighed 220 pounds. There were no signs of external 
acute injury, nor any material found within the nose, mouth or ears.  Upon 
further external examination, there were no significant abnormalities albeit 
cyanosis of the fingernail beds and glue marks in areas where EKG 
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medical tags were placed prior to resuscitation efforts (Elizabeth 
Laposata, personal communication, November 13, 2012). 
The body underwent internal examination. The organs were 
examined for any internal anomalies. Fluids were obtained from the 
individual that included blood from the heart and femoral artery, vitreous 
fluid, bile and gastric contents. Fluids were collected and toxicological 
analysis was done. The head showed signs of cerebral edema but no 
signs of softening, discoloration, or herniation. The neck contained a small 
amount of red-brown colored unobstructive mucus. The respiratory 
examination showed no signs of obstructive mucus, tumor or 
hemorrhages.  There were physical signs of hepatomegaly, or an enlarged 
liver (Elizabeth Laposata, personal communication, November 13, 2012).    
Upon cardiovascular examination, the heart appeared to be of 
normal appearance weighing 525 grams.  Normal levels of epicardial fat 
were noticed. Neither atrium showed any signs of thrombus. The interatrial 
and the interventricular valves were still intact.  The left and right ventricles 
appeared normal. Upon surgical dissection, the left and right ventricles 
contained clotted blood. Serial sections, taken approximately at 2 
millimeter intervals, showed 95% luminal stenosis of the left descending 
coronary artery and on average 75% stenosis everywhere else.  Stenosis 
of the left circumflex coronary artery and the right coronary artery was 
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additionally observed (Elizabeth Laposata, personal communication, 
November 13, 2012).   
Based on the observed physical observations, the cause of death 
stated by the medical examiner was atherosclerotic coronary artery 
disease. (Elizabeth Laposata, personal communication, November 13, 
2012). Since no post-mortem testing methods are diagnostic of a 
myocardial infarction, the medical examiner must explain that the cause of 
death was an arrhythmia that “may have been” (Elizabeth Laposata, 
personal communication, November 13, 2012) caused by hypoxic 
ischemia.  The medical examiner must explain the basis of her opinion to 
a reasonable degree of medical certainty based upon observation and 
subjective medical analysis. Besides toxicological examination of bodily 
fluid, no biochemical techniques were used to identify the dysfunction 
associated with cardiac tissue.    
 
 
II. Proposed Solution  
Sudden cardiac death (SCD) is “a rapid unexplained death due to 
cardiac causes” [3]. It is essential to address the importance and 
limitations of testing for SCD. To this date, the ability to visualize the 
biochemical dysfunction that connects the physiological stress to an acute 
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heart attack has not been used as a tool in the forensic setting. These 
cellular dysfunctions cannot be visualized under gross microscopic 
examination. SCD is a common form of heart disease, usually occurring 
within one hour of an abnormal physiological response.  In some cases, a 
misdiagnosis may occur [3]. Batalis et al. states that “one problem with the 
studies to date (including the current study) is that these studies have 
tested post-mortem cardiac markers in obvious patients with acute 
myocardial infarction and compared them to patients that were not cardiac 
deaths… it may prove more difficult to apply this data to the more subtle 
patients lacking definitive gross or microscopic cardiac pathology ”[1].  The 
majority of SCD has been attributed to acute fatal arrhythmias in which 
80% has been linked to coronary artery disease. The etiological basis 
pertains to both acute ischemic events and chronic ischemic heart 
disease.  The remaining percentage, 10%-15%, has been associated with 
ischemic diseases associated with dilated and hypertrophic 
cardiomyopathies.  A small fraction of ischemic disease is associated with 
less common disorders such as right ventricular (RV) dysplasia, lesions of 
molecular structures, and functional abnormalities. Contributing factors 
that help to identify high risk individuals such as age, gender, family 
history, smoking and hypertension are limited in that they do not explain 
the pathophysiological and biochemical events that occurs within the body 
[16]. There are certain cases in which there is little to no gross histological 
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indication of myocyte injury in assumed myocardial injury [1].  This paper 
suggests that SCD is attributed to apoptosis; the biochemical pathway that 
links irreversible cellular damage to an arrhythmia caused by hypoxic 
ischemic events.     
It is important to note that the articles reviewed came from sources 
relevant to not only forensic medicine but also from experimental and 
clinical applications. Analysis of available data in the scientific literature 
was conducted using the quality of evidence ratings stated by Donahue 
[17]. The reports, experimental and clinical studies will be collected and 
assessed to rate the quality of the data. 
Donahue’s ratings are quoted below and are as follows:  
“I: Consistent evidence obtained from more than 2 
independent, randomized, and controlled studies or from 2 
independent, population-based epidemiologic studies. Studies 
included here are characterized by sufficient statistical power, 
rigorous methodologies, and inclusion of representative 
patient samples. Meta-analysis of smaller, well-characterized 
studies may support key findings. 
II: Consistent evidence from 2 randomized controlled studies 
from independent centers, a single multicenter randomized 
controlled study, or a population-based epidemiologic study. 
Data included here have sufficient statistical power, rigorous 
methodologies, and the inclusion of representative patient 
samples. 
III-1: Consistent evidence obtained from 2 or more well-
designed and controlled studies performed by a single 
research group. 
III-2: Consistent evidence obtained from more than 1 study 
but in which such studies have methodologic constraints, 
such as limited statistical power, or the inclusion of patient 
samples that may be nonrepresentative. 
III-3: Evidence obtained from a single case study or a 
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selected cohort study. 
III-4: Conflicting evidence obtained from 2 or more well-
designed and controlled studies. 
IV: Consensus opinions of authorities according to clinical 
experience or descriptive reports”[17]. 
 
The literature investigation was conducted using Boston 
University’s School of Medicine proxy server from January 2012-
November 2012. The search included the use of Google Scholar, 
electronic journals available from Boston University, and Pub-Med search 
terms that included word, phrases, or combinations thereof listed in Table 
2.  
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Acute Cardiac Death Hemotoxylin and Eosin 
Apoptosis Hypoxia Inducible Factor 
Atherosclerosis Hypoxia 
B-Cell Lymphoma Immunocytochemistry 
Cardiac Failure Immunohistochemistry 
Cardiac Myocytes Myocardial Infarction 
Cardiac Troponin Coronary Artery Disease 
Coronary Artery Disease Quality of Evidence 
Evidence-based medicine Sudden Cardiac Death                      
Forensic Autopsy Sudden Ischemic Heart 
Forensic Medicine TUNEL Staining Method 
Table 2 states the keywords used during the literature search. 
To summarize, this paper will address the identification of proteins that 
are involved in cellular apoptosis. Proteins involved can be identified 
starting from the physiological hypoxic condition of tissue that leads to pro-
apoptotic protein effecters of irreversible cellular damage prior to an 
arrhythmia. These proteins include both the p53 and hypoxic inducible 
factor 1-alpha (HIF-1α) proteins which elevate due to hypoxic ischemic 
conditions [18].  The immunohistochemical (IHC) staining method for 
visualizing apoptotic proteins will be evaluated as a tool for forensic 
investigation to accurately identify acute sudden cardiac death.   
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III. Methods 
 
 
Paraffin-embedded, formalin fixation and sectioning    
A histologist will often use paraffin-embedded and formalin-fixed 
tissue sections for laboratory analysis and tissue preservation [19]. 
Paraffin wax embedding is a technique that helps to process a large 
amount of tissue within a short period of time. The paraffin is essentially 
made of organic wax and other petroleum components that are malleable 
under certain temperatures. Other products, such as beeswax and rubber, 
can be included in the paraffin product. Most immunohistochemical 
techniques use low heat to embed tissue to help maintain its physical 
inactive antigenic integrity [19].  
             A fixative alters the cells by stabilizing the protein to prevent, to 
the extent possible, any further physical or chemical changes. Common 
reagents for fixation, such as formaldehyde and mercuric chloride, create 
chemical linkages that prevent cell shrinkage. The functions of a fixative 
include: prevention of further putrefaction, autolysis and the maintenance 
of the proper cell structure and its extracellular and intracellular 
components [19].  
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          Rotary microtomes are used for sectioning formalin fixed paraffin- 
embedded tissues in most histology laboratories. The embedded tissue 
and microtome blade is placed into their designated clamp positions and 
the section thickness setting is chosen. The sharpness of the microtome 
blade, the speed in which tissue sections are cut, the angle of the blade 
and the thickness of the tissue are all factors of consideration when 
sectioning tissue [19].  
 
 
Immunohistochemical staining methods  
         An antigen is a foreign protein-based molecule that when introduced 
into the body provokes an immune response that stimulates the 
production of antibodies that react and bind with the antigen. Antibodies, 
or immunoglobulin (Ig), are used by the immune system to help identify 
and neutralize substances foreign to the body. The use of IHC staining 
allows the investigation of specific antigen-antibody complexes [19].    
An antibody is created to combat any agent foreign to the body 
[19]. In mammals, there are five classifications of Ig: IgG, IgA, IgE, IgD, 
and IgM. The molecular weight of the IgG classical “Y” shaped 
configuration is approximately 150kD and is expressed on the outer 
membrane surface of a cell [4, 19]. The “Y”-shaped protein consists of four 
polypeptide chains. Two light and heavy chains held together by di-sulfide 
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bonds create to form the Y-shaped protein. The ends of the forked 
positions form the antigen binding sites [20] (Figure 5). 
 
 
 
Figure 5 depicts an illustration of any antibody or IgG.  The two heavy 
chains are hinged together by di-sulfide bonds and the variable regions 
are located on the distal portion of the antibody [16].  
To be visualized microscopically, antigen-antibody complexes must 
incorporate an identification label. An identification label is commercially 
made and can be used to quantitatively or qualitatively observe for a 
specific antigen. The labels used in immunohistochemistry include but are 
not limited to: enzymatic, flourophore, colloidal gold, or biotin labels which 
allows visualization of the antigen-antibody complex [21].   
Immunohistochemical staining is performed utilizing either one of 
two methods: direct and indirect.  The direct method is a straight-forward, 
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one-step process. The antibody, along with its specific label, is utilized to 
access the questioned antigen. The direct staining method is a technique 
rarely used in routine IHC staining due to its lack of sensitivity and poor 
signal amplification [21, 22] (Figure 6).   
The biochemical pathway of apoptosis is cellular dysfunction that 
cannot be grossly seen after the onset of a myocardial infarction, 
therefore; the visualization of antigens related to apoptosis can prove to 
very difficult. This event is not easily detected and the visualization of the 
proteins involvedrelies on the more sensitive procedure called the IHC 
indirect staining method.  
 
 
Figure 6 shows direct immunohistochemical labeling method using a 
primary antibody [21].   
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The IHC indirect staining method has a higher sensitivity due to the 
use of a bound unlabeled primary antibody which is visualized with a 
secondary labeled antibody molecule marker such as a flourophore or 
enzyme. For example, studies using this technique detect the hypoxia 
inducible factor-1 alpha (HIF-1α) protein in the ischemic regions of 
damaged cardiac myocytes. This involved the application of an unlabeled 
HIF-1α monoclonal antibody, incubation of the tissue to prevent any 
unwanted nonspecific binding, followed by the addition of a fluorescent 
anti-immunoglobulin conjugate that binds to the HIF-1α monoclonal 
antibody [23, 24].   
 
Figure 7 shows indirect immunohistochemical labeling method using 
primary and secondary antibodies for ag-ab epitope amplification [21]. 
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It is important for the analyst to be knowledgeable of techniques 
helpful in retrieving antigen-masked epitopes that otherwise affect 
antigenicity. In current literature, antigen retrieval can be induced by 
simple and cost efficient methodology such as steam water baths, 
microwave heat-induced methodology and the use of laboratory buffers 
[21, 22].    
Similar to IHC, immunocytochemistry (ICC) uses antibodies to 
detect and visualize antigens. IHC and ICC are used interchangeably in 
the literature due to its common goal: to detect epitope-antibody 
interactions with one fundamental difference. IHC deals with tissue 
sections while ICC deals cell cultures and suspension. Indirect 
immunocytochemistry, similar to indirect immunohistochemistry, is the 
technique of choice since an unlabeled primary antibody and a labeled 
specific secondary antibody can be used to increase antigenic 
visualization [25].  
 
 
TUNEL staining method 
One of apoptosis’ unique characteristics involves deoxyribose 
nucleic acid (DNA) fragmentation seen in damaged tissue. One unique 
method used to visualize the presence of fragmented DNA is called the 
terminal deooxynucleotidyl transferase-mediated desoxyuridine 
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triphosphate nick-end labeling (TUNEL) staining method. The biologically 
programmed breakdown of the cardiac myocyte due to apoptosis leaves 
evidence of cellular death. Knowing this, the examiner can investigate 
apoptotic cell death upon nuclear DNA fragmentation [26].  
 During apoptosis, increased endonuclease activity results in the 
fragmentation of a free 3’hydroxyl group on the DNA strand. A 
manufactured terminal deoxynucleotidyl transferase (TdT) recognizes and 
attaches onto free 3’hydroxyl group on the DNA strand. The TUNEL 
staining method utilizes deoxyuridine triphosphate (dUTP) to extend its 
own dUTP independent template from the 3’ hydroxyl group. An additional 
labeling step utilizes fluorescein isothyocanate (FITC): which is an 
immunolabeled antibody that binds with the dUTP template in order to 
visualize the fluorescent marker indicative of DNA fragmentation [27, 28] 
(Figure 8). 
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Figure 8 shows illustration of the TUNEL staining assay as an example of 
TdT amplification of FITC-dUTP labeled break sites [29, 30]. 
Studies using the TUNEL staining method have demonstrated qualitative 
and quantitative presence of apoptosis in from an acute myocardial 
infarction, however; there have been experimental studies that showed 
unexpected apoptotic nuclei found in non-ischemic regions of the heart. 
[31]. Therefore, the use of the TUNEL staining method is helpful in 
locating apoptotic damage but must be interpreted cautiously in 
determining damage due to hypoxic ischemia.  
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IV. Results 
 
 
Relevance of proteins leading to apoptosis   
The availability of oxygen plays an important role in the cell’s ability 
to maintain homeostasis [24]. The argument presented in this paper 
suggests that the lack of oxygen, due to atherosclerosis, promotes 
irreversible cellular damage. This can result in elevated levels of protein-
based antigens attributed to cell death.    
Studies have shown that the HIF-1α protein is not only involved in 
apoptosis, but can induce the alteration of  gene transcription that includes 
the growth of new blood vessels or angiogenesis, vascular remodeling, 
erythropoiesis, metabolism, and apoptosis [32]. The HIF-1α protein is 
highly expressed in cardiac myocytes associated with low levels of 
oxygen.  The effects of the HIF-1α protein were studied in non-cardiac 
related deaths that included cardiac tissue from gunshot wounds or from 
individuals who have fallen from a certain height [24]. It is important to 
note that a study highlighted negative controls from individuals diagnosed 
with conditions that resulted from asphyxiation i.e. strangulation, hanging 
and drowning [33]. With these results, studies can conclude that the 
visualization of the HIF-1α protein is highly expressed in natural deaths, in 
contrast with other manners of death such as accidental, suicide and 
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homicide. The HIF-1α protein alone cannot, in succession, initiate the 
process of apoptosis. This suggests that the HIF-1α protein may be used 
to presumptively test for hypoxia and more critical tests must be taken.  
A second critical marker that suggests apoptotic cell death is the 
identification of the p53 protein. The p53 protein is elevated after the onset 
of physiological stress, however, under normative conditions; the p53 
protein is a tumor suppressor regulator which relies on the process of 
ubiquitization in order to maintain normal protein levels. The human 
double minute oncogene (Hdm-2) operates by antagonizing the p53 gene 
in the nucleus. This Hdm-2 oncogene encodes the p53 protein to attract 
chains of ubiquitin as the p53 protein is expressed in the cytoplasm of the 
cardiac myocyte. This event, also known as ubiquitization, allows the p53 
protein to exist in baseline levels in healthy cardiac tissue under normal 
conditions [9] (Figure 9).    
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Figure 9 shows normal ubiquitization conditions of p53 and Hdm-2 
between the nucleus and cytoplasm of a cell [9]. 
 
Under hypoxic stress, the p53 protein fails to degrade allowing 
accumulation of the p53 protein within damaged tissue. Studies indicate 
that the elevation of hypoxic conditions causes the p53 protein itself to 
amass in the nucleus of a cell. The overexpression of the p53 protein 
activates cellular transcription and increases the cardiac myocyte’s 
chance that apoptosis may be induced [9, 34].      
Although the p53 protein can respond to irreversible damage, it is a 
multifaceted biomarker in which additional factors attributing to the 
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protein’s elevated state may also cause cellular accumulation. Studies 
have shown that p53 is not only linked to apoptosis but DNA repair, cell 
cycle arrest and angiogenesis blockage. Additional studies have shown 
that other varieties of physiological effects such as oncogenic signaling, 
lack of nucleotides, and the blockage of transcription can cause an 
increase in p53 levels [9].  
 
 
Apoptosis and the caspase cascade  
Once the irreversible cellular damage by an atherosclerotic rupture 
of plaque has led to an increase in biochemical activity and elevated levels 
of HIF-1α and p53 protein that may identify the beginnings of an 
arrhythmia, the process of apoptosis is signaled to begin. Apoptosis is a 
programmed chain of events in which the body eliminates dead cells that 
may be redundant, damaged, and infected. Apoptosis is physiologically 
planned and vital for normal development and cellular homeostasis. 
Through this irreversible event, apoptosis signals a cascade of enzymes 
specific to cell death signaling [35] (Figure 10).  These enzymes, also 
known as caspases, further signal downstream pro-apoptotic protein 
effectors that continue the task of cell injury [35].  
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Figure 10 depicts procaspase activation and the caspase cascade. One 
molecule of active caspase A, once subjected to cytosolic protein 
procaspase cleavage, can activate more procaspase molecules [20]. 
 
Caspases are enzymes created, initially, as inactive enzymatic precursors 
found in the cell’s cytoplasm. These precursors, or procaspases, are 
activated upon elevated physiological stress triggering a chain reaction of 
cytosolic cleavages.  This initiates additional caspases to signal cell death 
from both inside and outside an individual cardiac myocyte (Figure 13). 
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The common structure of a caspase includes an enzymatic prodomain, an 
active binding site and a carboxyl acid at its terminal end [35]. The active 
binding site is a pentapeptide consisting of the amino acids: glutamine 
(Gln), Alanine (Ala), Cysteine (Cys), Arginine (Arg) and Glycine (Gly) [36]. 
Characteristics of caspase activity includes: the activation of key proteins 
in a cell and cleavage of nuclear lamina which helps maintain nuclear 
integrity [20, 36] (Figure 10). 
  
 
The intrinsic and extrinsic apoptotic pathways 
Irreversible cell death has two phases. The first phase is the cell’s 
irreversible decision to execute cell death. The second is its intracellular, 
morphological, and biochemical pathways that commit to these alterations 
produce and injuries [37]. The two biochemical pathways relevant to 
cardiac cell death are the body’s internal intrinsic and extrinsic apoptotic 
pathways [20].  
The intrinsic pro-apoptotic related pathway initiates its programming 
when elevated levels of both the HIF-1α protein and based upon contrary 
studies, the p53 protein. This programmed response focuses on the 
release of cytochrome C from injured mitochondria. Under normal 
conditions, cytochrome C is a water soluble heme protein that plays an 
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important role in electron transport. The process of oxidative 
phosphorylation allows entry of electrons into the cell’s inner mitochondrial 
membrane. Four membrane bound protein complexes (I-IV) help pass 
electrons through the cell’s inner mitochondrial membrane. With the aid of 
electron carriers such as ubiquinone, cytochromes and iron-sulfur proteins 
(Figure 11), the transfer of electrons create an exogenic reaction that 
dispenses protons out of the membrane. This generates a mitochondrial 
membrane potential that drives the organelle to synthesize adenosine 
triphosphate (ATP). The role of cytochrome C is to accept electrons from 
protein complex III, as it readily diffuses into complex IV, to create 
cytochrome oxidase.   Electrons are donated to convert O2 into H2O to 
further fuel ATP production [38] (Figure 11). 
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Figure 11 showing Cytochrome C and its role in oxidative phosphorylation 
[38]. 
 
Anti-apoptotic proteins are located around the outer membrane 
boundary of the cellular matrix. Damage due to the decrease in oxygen 
subsequently decreases ATP production and results in pro-apoptotic 
protein buildup. This causes the release of cytochrome C from the 
mitochondrion as it permeates towards the cellular cytoplasm [9, 39] 
(Figure 12).   
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Figure 12 depicts cytochrome C leakage due to mitochondrial injury and/or 
dysfunction [30]. 
 
The release of cytochrome C signals a downstream effect of pro-
apoptotic proteins and enzymes to create an apoptosome. An 
apoptosome is considered an “oligomeric signaling platform” [30] 
consisting of adapter proteins and signaling caspases, which induce 
further intrinsic signaling. The apoptosome is another cell signaling 
molecule that  recruits additional caspases to further cell death [20, 30] 
(Figure 13).  
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Figure 13 illustrates the apoptotic intrinsic pathway conditions. 
Cytochrome C is leaked from the mitochondria of the cell activating the 
binding of the adapter protein with aggregate binding of caspase [20]. 
 
The extrinsic pro-apoptotic pathway relies on the activation of 
protein receptors located on the cell’s outer membrane surface. The 
receptors are activated during ag-ab physical conformation. For example, 
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the cell has the ability to initiate apoptosis by utilizing proteins responsible 
for intercellular signaling. The  tumor necrotic factor-1 alpha (TNF-1α) is 
categorized as a cytokine: a group of specific proteins that are released 
from cardiac myocytes and are involved in an immunopathological 
process that include features associated with atherosclerotic lesions, 
cardiac myocyte inflammation and heart failure [40]. Upon hypoxic 
conditions, the TNF-1α protein binds to its appropriate receptor outside the 
membrane of the cardiac myocyte and relies on the physical confirmation 
of the antigen and antibody epitope binding sites to signal adapter proteins 
and procaspases. Similar to the intrinsic pathway, this promotes the 
activation of a caspase cascade that precedes cell death [20] (Figure 14).  
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Figure 14 illustrates the apoptotic extrinsic pathway conditions.  TNF-1α 
binds to its specific receptor on the surface of the target cardiac myocyte. 
The activation of a procaspase and the adapter protein  initiates the 
extrinsic caspase cascade [41]. 
Although the name can be deceiving, elevated TNF-1α protein is 
indicative of extrinsic apoptotic factors from sudden cardiac symptoms 
such as ventricular dysfunction, inflammation and hypoxia. A study on 
TNF-1α protein and its effects in ventricular fibrillation with acute 
myocardial infarction was explored by Chen et al [42]. Acute myocardial 
infarction of the left atrial appendage and left anterior descending coronary 
artery was induced by ligation in male rats. Results showed the response 
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time for visualizing accumulation of TNF-1α protein within ischemic tissue: 
10 minutes after the myocardial infarction. The amount of TNF-1α protein 
observed plateaued approximately 20-30 minutes after infarction 
compared to the sham group which showed no remarkable levels of TNF-
1α protein [42]. Studies showed that the TNF-1α may be pathologically 
linked to the HIF-1α protein [37, 43] and has been speculated that TNF-1α 
protein activates once bounded to extracellular receptors present outside 
of cardiac myocytes. The TNF-1α protein is not only a mediator apoptosis, 
but can also trigger apoptotic changes in additional cell types [37, 43, 44]. 
  
 
B-Cell lymphoma 2 (Bcl-2) family   
Studies show the B-Cell lymphoma (Bcl-2) family of proteins play a 
major role in programmed cell death in addition to their effects on 
lymphoma: which is a problematic issue in benign aggregation of cells and 
cancerous malignancies [45]. The Bcl-2 family of proteins is located on the 
outer surface membrane of the mitochondrion. The Bcl-2 family of proteins 
is regulated by the Bcl-2 gene and is activated during chromosomal 
transfer from the 18q21 position to an active 14q32 position. The Bcl-2 
protein is approximately 25-26 kD and has a 19 amino acid hydrophobic 
40 
 
hydrocarbon cleft and a carboxyterminal transmembrane region at the 
opposite end [46].   
Under normative conditions, anti-apoptotic proteins, such as the 
Bcl-2 and B-Cell Lymphoma XL (Bcl- XL), help to inhibit apoptosis [47]. 
These anti-apoptotic proteins interact with their pro-apoptotic counterpart. 
The joining of two polypeptide chains composed of various subunits is a 
process called heterodimerization. The heterodimer formation of a Bcl-2 
anti-apoptotic protein with their pro-apoptotic family member is the null 
form of apoptotic proteins that induces cell proliferation. Studies have 
shown that these anti-apoptotic proteins prevent any physiological 
damage occurring such as cytochrome C leakage from the mitochondrion 
[9]. Additional studies have tested that anti-apoptotic Bcl-2 proteins not 
only delay, but prevent early associated morphological apoptotic 
characteristics such as DNA degradation, nuclear fragmentation and 
chromatin condensation [46].    
Upon physiological stress and hypoxic induced damage, pro-
apoptotic proteins such as the Bcl-2 Associated X (BAX) protein, modifies 
its physical shape from a closed loop protein strand to a physical open 
loop confirmation [48]. This allows the BAX protein to open its active 
binding site to induce apoptosis and stimulate the release of cytochrome C 
in the mitochondria [53, 54]. When the BAX protein is in excess, and the 
ratio of pro to anti-apoptotic antigens is high, the cell is susceptible to 
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death [47, 49, 50]. Additionally, the Bcl-2 Associated Killer (BAK) is a 
protein that elevates during apoptosis and is similar to the BAX protein. 
The functional properties of the BAX and BAK proteins allow them to 
congregate at the outer surface of the mitochondria, overwhelming anti-
apoptotic proteins, and cause the collapse of ATP production [9]. It is 
important to note that overexpression of the Bcl-2 family proteins may 
converge from either intrinsic or extrinsic apoptotic stress. The Bcl-2 family 
of proteins help visualize the downstream effects of apoptosis, but cannot 
lead the investigator to state which apoptotic pathway initiated the Bcl-2 
activation [46].       
 
 
Quality of Evidence     
The Quality of Evidence literature analysis consisted of 17 articles. 
The majority of the articles fell within the III-2 category. Multiple references 
listed in Table 3 denote multiple staining methods used for those 
respective studies. 
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Table 3 lists the Quality of Evidence ranking as described by Donahue 
[17].   
 
The quality of data ranked within the III-2 category which consisted of 
experiments that included: more than one study with methodologic 
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constraint, limited statistical power, and a non-representative sample.  The 
quality of the data listed in category III-3 failed to provide statistical 
analysis that would otherwise strengthen the usage of IHC staining. The 
sole reference listed in category IV was a review of apoptosis. 
Additional information was shown in Table 4 and Table 5 to 
highlight the quality data listed in category III-2. Additional factors were 
implemented to investigate the effects of cardiac ischemic cases from their 
control groups to suggest a strong correlation evident to the utilized 
staining methods. The data categorized included: donors that were 
diagnosed with an acute myocardial infarction and animals that were 
manually litigated to mimic a myocardial infarction. In addition, the 
references focused on the left ventricle of the heart because of its 
involvement with oxygenated blood and its response to hypoxic ischemic 
conditions. The mean percentages of the number of hearts used for 
testingwere calculated to indicate any positive correlation with the staining 
methods.  
Reference [61] and [62] listed as a ranking of III-2 was statistically 
relevant to the information compiled, however; their studies did not focus 
on aforementioned factors. Their studies included: congestive heart 
failure, right ventricular cardiomyopathies and caspase visualization. They 
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were not included in Tables 4 and 5. The control findings are highlighted in 
Table 4.  
 
Table 4 shows the III-2 data corresponded with the non-cardiac related 
deaths used for each experiment. 
 
The study conducted by Zhu et. al. included control groups of 
cardiac tissue from other forms of asphyxiation i.e. strangulation, hanging 
and drowning [33]. The HIF-1α protein showed no evidence of 
accumulation in the control group and may suggest these manners of 
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death, which results in lack of oxygen but do not induce damage to the 
heart, do not result in increased accumulation of HIF-1α in the heart 
tissue. It is interesting to note that although a negative value should 
theoretically correspond to a negative result, this was not the case for the 
Bcl-2 study. Visual staining for the pro-apoptotic Bcl-2 failed to produce a 
strong correlation and staining occurred in the control group respectively. 
The results of the experimental group from the III-2 category are 
listed in Table 5.  
Table 5 shows the III-2 experimental data corresponded with an AMI or 
the manual litigation of test subjects.  
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The data showed a positive correlation in experiments involving the 
TUNEL staining method and the HIF-1α staining method and the presence 
of an acute myocardial infarction.  Data developed using the visualization 
of Bcl-2, p53 and TNF-1α proteins either failed to provide any statistical 
analysis in the conclusions or the limited data was insufficient to correlate 
the findings with sudden cardiac death from hypoxic ischemic conditions.       
 
 
V. Discussion 
The purpose of this literature investigation was to evaluate whether 
the presence of apoptotic biomarkers identified in various experimental 
studies and post-mortem autopsies could be used as indicators of hypoxic 
ischemic conditions that lead to an arrhythmia. The majority of sources 
concluded that IHC staining can be used as a tool to identify apoptotic 
related hypoxic ischemic conditions but no one method alone can indicate 
an acute myocardial infarction. However; there is sufficient data to suggest 
that a combination of staining methods, preferably in the visualization of 
using the IHC staining method to identify HIF-1α protein and DNA 
fragmentation using the TUNEL staining method indicates the presence of 
hypoxic ischemic tissue. The methods used to experimentally identify a 
myocardial infarction varied in protocol, outcome, sensitivity and 
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specificity. Common in the literature, IHC and ICC staining techniques 
proved effective for visualizing hypoxic ischemia in cardiac tissue. In 
addition, the TUNEL staining method was used to observe for DNA 
fragmentation: a physical characteristic associated with apoptosis.   
It is clear that the quality of evidence rating provided in Table 3 is 
consistent with information that has established a new insight into the 
direction that SCD research can go.  Compiling the reports that described 
the various staining methodologies used to diagnose sudden cardiac 
death proved to be challenging due to the inconsistency of acute ischemic 
injury and myocardial infarcted related subjects. The subjects used in 
these investigations were tissue from animals that were manually 
litigatedor humans that were already diagnosed with a myocardial 
infarction.  For the investigation to be more effective, pilot studies should 
include specimens from possible infarct victims from various populations 
and additional non-effected specimens selected at random. The majority 
of the research evaluated lacks a consistent methodology due to the 
various clinical, hospital and forensic settings. The methodologies chosen 
for this investigation are consistent with more than one study but were 
restricted to limited data analysis and non-randomized groups.  Methods 
of induced infarctions varied in protocol that included but were not limited 
to: manual suture and strangulation, anesthetic, chemically induced 
myocardial infarcts and human tissue donors. Rarely has a study used 
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IHC staining alone without other complementary techniques such as 
western blotting, RT-PCR and ELISA that would confirm the investigator’s 
hypothesis. No test alone indicated the use of IHC staining as the sole 
confirmed resource for sudden cardiac death, although collectively; the 
results indicate that identification of the HIF-1α and DNA fragmentation 
can be an invaluable tool. 
From a forensic standpoint, combining the uses of various staining 
methods would help construct a more accurate and representative 
diagnosis. A forensic investigator should be careful in examining an 
individual who was suspected of sudden cardiac death and should assess 
the physical signs during post-mortem examination. The forensic 
pathologist should proceed with a postmortem examination that includes a 
human heart surgical autopsy. By integrating the knowledge of sudden 
cardiac death from other resources with forensic medicine, one can take 
into account which journal would be most appropriate to a specific 
audience.    
 
 
VI. Future Considerations      
Tissue, in itself, has an inherent internal positive control [19]. The 
expansive study on the HIF-1α protein, as suggested by Pampin et al. 
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[24], adjacent with the TUNEL staining method on a cardiac myocyte 
would strengthen the idea of identifying multiple apoptotic biomarkers 
found on the victim. A consistent and prospective study in order to 
strengthen the current literature of SCD and help comply with the 
suggested standards set forth by the National Academy of Sciences would 
be advantageous for the forensic science community.  It was stated 
through recommendation 11c “best practices should include the utilization 
of new technologies such as laboratory testing for the molecular basis of 
diseases” [51].  Sufficient data supports the initiative that research in IHC 
staining methodology can be an effective tool to help investigators 
positively identify an acute myocardial infarction. 
 
References in quality of evidence rating necessary:[2, 24, 28, 31, 33, 42, 52-
54][55][56][57][58][59][60][61, 62] 
    
 
 
 
 
 
 
 
 
50 
 
 
VII. References  
 
1. Batalis, N., et al., The Role of Postmortem Cardiac Markers in Diagnosis 
of Acute Myocardial Infarction. The Journal of Forensic Sciences, 2010. 
55(4): p. 1088-1091. 
 
2. Edston, E., L. Grontoft, and J. Johnsson, TUNEL: A Useful Screening 
Method In Sudden Cardiac Death. International Journal of Legal Medicine, 
2002. 116: p. 22-26. 
 
3. Gill, J., R. Lange, and O. Azar, What Is Sudden Cardiac Death? Academic 
Forensic Pathology, 2011. 1(2): p. 176-187. 
 
4. Silverthorn, D., Human Physiology: An Integrated Approach. Vol. 4. 2009: 
Pearson/ Benjamin Cummings. 
 
5. Clayman, C., The Human Body: An illustrated Guide to its Structure 
Function and Disorders, ed. C. Clayman. Vol. 1st Edition. 1995, London: 
DK Publishing book. 
 
6. Pierce, E., File: Diagram of the human heart.svg, 2006.Retrieved from 
http://commons.wikimedia.org/wiki/File:Diagram_of_the_human_heart_%2
8cropped%29.svg 
 
7. Young, B., et al., Wheater's Functional Histology: A text and Colour Atlas. 
Vol. 5th Edition. 2006, Philadelphia, PA: Elsevier. 
 
8. RCA atherosclerosis.jpg 2, 2009 Retrieved from http://commons.wikipedia 
.org/wiki/File:RCAatherosclerosis.jpg 
 
9. Weinberg, R., The Biology of Cancer, Vol. 1st Edition. 2007, New York, 
NY: Garland Science. 
 
10. Hannson, G.K., Inflammation, Atheroschlerosis, and Coronary Artery 
Disease The New England Journal Of Medicine, 2005. 1(352): p. 1685-95. 
 
11. Kumar, V., R. Cotran, and S. Robbins, Basic Pathology, 7th Edition. Vol. 
7th Edition. 2002, Philadelphia: W.B. Saunders. 
 
12. Dix, J., Handbook for Death Scene Investigators. 1999, Boca Raton, 
Florida: CRC Press. 
51 
 
 
13. Brinkman, B., M.A. Sepulchre, and G. Fechner, The Application of 
Selected Histochemical and Immunohistochemical Markers and 
Procedures of the Diagnosis of Early Myocardial Damage. International 
Journal of Legal Medicine, 1993. 106: p. 135-141. 
 
14. Duncanson, E. and S. Mackey-Bojack, Adult Heart Dissection Technique. 
Academic Forensic Pathology, 2011. 1(2): p. 148-156. 
 
15. Ilia, R., et al., Left Anterior Descending artery length in left and right 
coronary artery dominance. Coronary Artery Disease, 2001. 12(1): p. 77-
79. 
 
16. Myerburg, R.I., Alberto; Mitrani, Raul; Kessler, Kenneth; Castellanos, 
Agustin., Frequency of Sudden Cardiac Death and Profiles of Risk The 
American Journal of Cardiology, 1997. 80(5B). 
 
17. Donahue, M., Evidence - Based Medicine and Shaken Baby Syndrome 
Part 1: Literature Review, 1966-1998. American Journal of Forensic 
Medical Pathology, 2003. 24: p. 239-242. 
 
18. Schmid, T.Z., Jie; Brune, Bernhard. , HIF-1 and p53: Communication of 
Transcription Factors Under Hypoxia. Journal of Cellular and Molecular 
Medicine 2004. 8(4): p. 423-431. 
 
19. Carson, F. and C. Hladik, Histotechnology: A Self-Instructional Text. 3rd 
Edition. 2009, American Society for Clinical Pathology: Weikersheimer, J. 
 
20. Alberts, B., et al., Molecular Biology of the Cell, ed. M. Anderson, B. 
Dilermia, and B. Goatly. Vol. 4th. 2003, New York, NY: Taylor & Francis 
Group. 
 
21. Buchwalow, I. and W. Bocker, Immunohistochemistry: Basics and 
Methods. Vol. 1st Edition. 2010, Heidelberg Dordrecht London New York: 
Springer-Valberg. 
 
22. IHC World, L. IHC World: Life Science Products and Services 2003-2011 
2011 [cited 2012 27 Oct 2012]; Available from: ihcworld.com/intro/lhc-
methods.html. 
 
23. IHC World, L. Immunohistochemistry: Catalyzed Signal Amplification 
(CSA) Method. 2013  [cited 2013 03/28/2013]; Available from: 
http://www.ihcworld.com/_protocols/general_IHC/csa_method.htm. 
52 
 
 
24. Pampin, J., et al., Immunohistochemical Expression of HIF-1 alpha in 
Response to Early Myocardial Ischemia. The Journal of Forensic 
Sciences, 2006. 51(1): p. 120-124. 
 
25. Burry, R., Controls for Immunocytochemistry: An Update. Journal of 
Histochemistry & Cytochemistry, 2011. 59(1): p. 6-12. 
 
26. Kim, J.S., L.H. He, and J.J. Lemasters, Mitochondrial Permeability 
Transition: A Common Pathway to Necrosis and Apoptosis. Biochemical 
and Biophysical Research Communications, 2003. 304(3): p. 463-470. 
 
27. Darzynkiewicz, Z.G., Dariusz; Zhao, Hong. , Analysis of Apoptosis By 
Cytometry Using TUNEL Assay. National Institute of Health: Methods, 
2008. 44(3): p. 250-524. 
 
28. Labat-Moleur, F., et al., TUNEL Apoptotic Cell Detection in Tissue 
Sections: Critical Evaluation and Improvement. Official Journal of the 
Histochemical Soiety, 1998. 46(3): p. 327-334. 
 
29. File: DNA helix structure.png, 2009. Retrieved from http://commons. 
wikimedia.org/wiki/File:DNA_helix_structure.png 
 
30. APO-DIRECTTM : A Complete Kit for Measuring Apoptosis by Flow or 
Laser Scannin Cytometry using the TUNEL assay, 2010. 
 
31. Piro, F., et al., Archives of Pathology and Laboratory Medicine, 2000. 124: 
p. 827-831. 
 
32. Giordano, F., Oxygen, Oxidative Stress, Hypoxia, and heart failure. The 
Journal of Clinical Investigation, 2005. 115(3): p. 500-508. 
 
33. Zhu, B.-L.,et al., Forensic Pathological Investigation of Myocardial 
Hypoxia-Inducible Factor-1alpha, Eruthropoietin and Vascular Endothelial 
Growth Factor in Cardiac Death. Legal Medicine, 2008. 10: p. 11-19. 
 
34. Kaelin, W., The Emerging p53 Gene Family. Journal of the National 
Cancer Institute, 1999. 91(7): p. 594-598. 
 
35. McCully, J., et al., Differential Contribution of Necrosis and Apoptosis in 
Myocardial Ischemia-Reperfusion Injury. American Journal of Physiology- 
Heart and Circulatory Physiology, 2004. 286: p. 1923-1935. 
 
53 
 
36. Wang, J. and M. Lenardo, Roles of Caspases in Apoptosis, Development, 
and Cytokine Maturation Revealed by Homozygous Gene Deficiencies. 
The Journal of Cell Science, 2000. 113: p. 753-757. 
 
37. Cohen, G., Caspases: The Executioner of Apoptosis. Biochemical Journal, 
1997. 326: p. 1-16. 
 
38. Ow, Y., et al., Cytochrome C: Functions Beyond Respiration. Nature, 
2008. 9: p. 532-542. 
 
39. Szeto, H., Mitochondria-Targeted Cytoprotective Peptides for Ischemia-
Reperfusion Injury. Antioxidants & Redox Signaling, 2008. 10(3): p. 601-
619. 
 
40. Mehra, V.R., Vinod; Bender, Jeffrey. , Cytokines and Cardiovascular 
Disease. Journal of Leukocyte Biology, 2005. 78(4): p. 805-818. 
 
41. Roth, W.R., John. , Apoptosis and Cancer: When BAX is Trailing Away. 
Nature Medicine, 2002. 8: p. 216-218. 
 
42. Chen, Y.-C.Z., Qing; Liao, Yu-Hua; Cao, Zhe; Du, Yi-Mei et. al. , Effects of 
Tumor Necrosis Factor-Alpha On Neutralization Of Ventricualr Fibrillation 
in Rats with Acute Myocardial Infarction Mediators of Inflammation 2011. 
 
43. Kaloustian, S., et al., Tumor Necrosis Factor-Alpha Particles in Apoptosis 
In the Limbic System After yocardial Infarction. Apoptosis, 2009. 14: p. 
1308-1316. 
 
44. Krown, K., et al., Tumor Necrotic Factor Alpha-Induced Apoptosis in 
Cardiac Myocytes. Journal of Clinical Investigation, 1996. 98(12): p. 2854-
2865. 
 
45. Alizadeh, A., et al., Distinct Types of Diffuse Large B-Cell Lymphoma 
Identified by Gene Expression Profiling. Nature, 2000. 403: p. 503-511. 
 
46. Reed, J., Bcl-2 and the Regulation of Programmed Cell Death. The 
Journal Of Cell Biology, 1994. 124(1&2): p. 1-6. 
 
47. Latif, N., et al., Upregulation of the Bcl-2 Family of Proteins in End Stage 
Heart Failure. Journal of the American College of Cardiology, 2000. 35(7): 
p. 1769-1777. 
 
54 
 
48. Gavathiotis, E., et al., BH3- triggered Structural Reorganization Drives the 
Activation of Proapoptotic BAX. Molecular Cell, 2010. 40(3): p. 481-492. 
 
49. Arnoult, D., et al., Mitochondrial Release of Apoptosis Inducing Factor 
Occurs Downstrea of Cytochrome C Release in Response to Several 
Proapoptotic Stimuli. The Journal Of Cell Biology, 2002. 159(6): p. 923-
929. 
 
50. Pawlowski, J. and A. Kraft, Bax-Induced Apoptotic Cell Death. 
Proceedings of the National Academy of Sciences, 2000. 97(2): p. 529-
531. 
 
51. Strengthening Forensic Science In the United States: A Path Forward. 
Vol. 1st Edition 2009: National Academy Press. 
 
52. Katstura, J., et al., Apoptotic and Necrotic Myocyte Cell Seath Are 
Independent Contributing Variables of Infarct Size in Rats. The United 
Sttes and Canadian Academy of Pathology, 1996. 74(1): p. 86-107. 
 
53. Black, S.C.H.J.Q.R., Parisa; Radinovic, Steve; Eberhart, Andreas; 
Nicholson, Donald; Rodger. Ian. , Co-localization of the Cysteine Protease 
Caspase-3 with Apoptotic Myocytes After In Vivo Myocardial Ischemia and 
Reperfusion in the Rat. Journal of Molecular Cell Cardiology, 1998. 30: p. 
733-742. 
 
54. Palojoki, E., et al., Cardiomyocyte Apoptosis and Ventricular Remodeling 
After Myocardial Infarction in Rats. American Journal of Physiology- Heart 
and Circulatory Physiology, 2001. 280: p. H2726- H2731. 
 
55. Bai, C.-G., et al., Regional Expression of the Hypoxia Inducing Factor 
(HIF) System and Association with Cardiomyocyte Cell Cycle Re-entry 
After Myocardial Infarction In Rats. Heart Vessels, 2008. 23: p. 193-200. 
 
56. Misao, J., et al., Coronary Heart Disease / Myocardial Infarction: 
Expression of Bcl-2 Protein, an Inhibotr of Apoptosis, and Bax, an 
Accelerator of Apoptosis, in Ventricular Myocytes of Human Hearts with 
Myocardial infarction. Circulation, 1996. 94(7): p. 1506-1512. 
 
57. Prech, M., et al., Apoptosis As A Mechanism for the Elimination of 
Cardiomyocytes After Acute Myocardial Infarction. The American Journal 
of Cardiology, 2010. 105: p. 1240-1245. 
 
55 
 
58. Dhingra, S., et al., p38 and ERK1/2 MAPKs Mediate The Interplay of TNF-
Alpha and IL-10 in Regulating Oxidative Stress and Cardiac Myocyte 
Apoptosis. American Journal of Physiology- Heart and Circulatory 
Physiology, 2007. 293: p. H3524-H2531. 
 
59. Xiao, H., et al., Positive Correlation in Tumor Necrosis Factor- Alpha Early 
Expression in Myocardium and Ventricular Arrhythmias in Rats with Acute 
Myocardial Infarction. Archives of Medical Research, 2008. 39: p. 285-
291. 
 
60. Kang, P.I., Seigo. , Apoptosis and Heart Failure: A Critical Review of the 
Literature Circulartion Research: Journal of the American Heart 
Association 2000. 86. 
 
61. Song, H.C.J., John V.; Foster, Andrew; McLaughin, Joseph; Wei, Chiming.  
Increased p53 Protein Expression in Human Failing Myocardium The 
Journal of Heart and Lung Transplantation 1998. 18(8): p. 744-749. 
 
62. Dewachter, C., et al., Activation of Apoptotic Pathways in Experimental 
Acute Afterload-Induced Right Ventriclular Failure. Society of Critcal Care 
Medicine, 2010. 38(6): p. 1405-1413. 
 
 
 
 
 
 
 
 
 
 
 
       
 
 
 
 
       VITA 
 
 
 
 
 
 
 
 
 
 
  
   
  
 
 
 
 
 
 
 
 
 
    
 
 
 
   
                                                                                                                                 
 
 
 
    
  
    
 
  
    
  
 
 
 
 
 
 
 
 
  
 
 
    
 
 
    
 
 \ 
 
  
 
 
   
 
  
 
  
 
 
 
 
 
 
  
 
  
   
 
  
 
 
                                                                                                                                                  
 
 
  
 
 
 
 
 
 
